Published in Arzneimittelforschung on November 01, 1968
The effect of amiodarone, a new anti-anginal drug, on cardiac muscle. Br J Pharmacol (1970) 5.24
Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors. Br J Pharmacol (1972) 4.53
Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias. Br Heart J (1980) 1.64
Effects of amiodarone on thyroid function in patients with ischaemic heart disease. Br Heart J (1975) 1.63
Cardiac actions in the dog of a new antagonist of adrenergic excitation which does not produce competitive blockade of adrenoceptors. Br J Pharmacol (1970) 1.47
Dangers of amiodarone and anticoagulant treatment. Br Med J (Clin Res Ed) (1981) 1.35
Amiodarone in the treatment of refractory supraventricular and ventricular arrhythmias. Postgrad Med J (1979) 1.31
Clinical antiarrhythmic effects of amiodarone in patients with resistant paroxysmal tachycardias. Br Heart J (1980) 0.97
Acute effects of amiodarone upon the canine sinus node and atrioventricular junctional region. J Clin Invest (1983) 0.81
Amiodarone. Biochemical aspects and haemodynamic effects. Drugs (1985) 0.79
Pharmacology of the myocardium: antiarrhythmic therapy. Proc R Soc Med (1976) 0.75
Enhanced Late Na and Ca Currents as Effective Antiarrhythmic Drug Targets. Front Pharmacol (2017) 0.75
Prognostic significance of electrocardiographic findings in angina at rest. Therapeutic implications. Br Heart J (1981) 0.75
An indolizine with an amiodarone-like haemodynamic profile [proceedings]. Br J Pharmacol (1976) 0.75
Action of amiodarone over the extension and reversibility of experimental myocardial infarction in pigs. Tex Heart Inst J (1984) 0.75
Sudden cardiac death and the potential role of beta adrenoceptor-blocking drugs. Postgrad Med J (1994) 0.75
Control of recurrent supraventricular tachycardia with amiodarone hydrochloride. Can Med Assoc J (1976) 0.75
Comparative in vitro and in vivo evaluation of three tablet formulations of amiodarone in healthy subjects. Daru (2010) 0.75
Effect of short and long term administration of amiodarone on ischaemia-induced left ventricular dysfunction. Implications for combined antianginal drug therapy. Drugs (1985) 0.75
Amiodarone. Haemodynamic profile during intravenous administration and effect on pacing-induced ischaemia in man. Drugs (1985) 0.75
[Detergent enzymes: has the risk of occupational sensitization disappeared?]. Rev Mal Respir (1992) 2.07
Cardiac actions in the dog of a new antagonist of adrenergic excitation which does not produce competitive blockade of adrenoceptors. Br J Pharmacol (1970) 1.47
[Research on the benzofuran series. XL. Anti-arrhythmic properties of amiodarone]. Cardiologia (1969) 1.06
Some biochemical effects of amiodarone. Arzneimittelforschung (1969) 1.05
Comparison of phosphatase isoenzymes PAP and PSA with bone scan in patients with prostate carcinoma. Clin Nucl Med (1991) 1.05
Opposite effects of amiodarone and -blocking agents on cardiac function under adrenergic stimulation. Arzneimittelforschung (1972) 0.90
[Studies of the benzofuran series. XXV. Hemodynamic effects of amiodarone in the dog]. Acta Cardiol (1967) 0.88
[Physiopathology of angina and long term antianginal medication. Current concepts]. Nouv Presse Med (1974) 0.87
[Studies in the series of benzofurans. XXIX. Effect of amiodarone on the metabolism of the heart in the dog]. Biochem Pharmacol (1967) 0.85
[Research on the benzofuran series. XXXII. Mode of action of amiodarone on the cardiovascular system]. Arch Int Physiol Biochim (1967) 0.84
Nature of the inhibition by amiodarone of isoproterenol-induced tachycardia in the dog. Arch Int Pharmacodyn Ther (1976) 0.81
[Characteristics and mode of action of amiodarone on cardiac output and stroke volume in the dog]. Arzneimittelforschung (1972) 0.81
[Research on the benzofuran series. XXVI. General pharmacological effects of amiodarone]. Arch Int Pharmacodyn Ther (1967) 0.80
Effect of carnitine on acidosis and ketosis induced by lipid perfusions in dogs during starvation. Biochim Biophys Acta (1965) 0.79
Serum levels of CA-50, CA-19.9, CA-125, CA-15.3, enolase and carcino-embryonic antigen in non neoplastic diseases of the lung. Anticancer Res (1988) 0.78
ROC analysis in radioimmunoassay: an application to the interpretation of thyroglobulin measurement in the follow-up of thyroid carcinoma. Eur J Nucl Med (1987) 0.77
Serum levels of CA-50, CA-19.9, CA-125, neuron specific enolase and carcinoembryonic antigen in lung cancer and benign diseases of the lung. Biomed Pharmacother (1989) 0.76
[Biologic effect of hypomagnetic environment]. Presse Therm Clim (1970) 0.76
[Study of human chorionic somatotropin (HCS) in normal and pathological pregnancies]. Ann Endocrinol (Paris) (1974) 0.75
[Letter: RH-LH test in psychogenic amenorrhea]. Nouv Presse Med (1975) 0.75
[Effect of magnetic field variations on the growth of various microorganisms]. J Physiol (Paris) (1967) 0.75
[Method of detection of bacterial mutations induced by cosmic rays]. Rev Med Aeronaut (1966) 0.75
[Letter: LHRH test in aged women]. Nouv Presse Med (1976) 0.75
[Proceedings: Hormonal variations before and after orchidectomy for two leydig cells' tumor (author's transl)]. Ann Endocrinol (Paris) (1976) 0.75
[Antithrombotic properties of inicarone]. Arch Int Pharmacodyn Ther (1973) 0.75
[Research in the benzofuran series. 8. Transit of 2-ethyl-3-(4-hydroxybenzoyl)-benzofuran in man and animals]. Arch Int Pharmacodyn Ther (1965) 0.75
[Research on the series of benzofurans. XXIV. Study of the behavioral effects of 5-(N-piperidinomethyl)coumarylamide]. Arch Int Pharmacodyn Ther (1967) 0.75
[Autoradiographic procedures and their importance for research. 2]. Rev Corps Sante Armees Terre Mer Air (1968) 0.75
[Simultaneous high performance liquid chromatographic determination of 8 anti-epileptics and sedatives in plasma. Use of a radial compression column system]. Ann Biol Clin (Paris) (1984) 0.75
[Tissue lesions caused by primary and secondary cosmic ray heavy ions]. Presse Therm Clim (1970) 0.75
[Determination of chorionic somatomammotropin hormone during isoimmunization by anti-D[]. J Gynecol Obstet Biol Reprod (Paris) (1976) 0.75
[Pharmacology of coronary circulation]. Rev Med Liege (1968) 0.75
[Pharmacology of the coronary circulation]. Rev Med Liege (1968) 0.75
[Studies on the benzofuran group. XLVI. The thrombolytic effect of benzarone]. Arzneimittelforschung (1972) 0.75
[Research on benzofuran series. XLV. Pharmacological properties of exetorone]. Therapie (1972) 0.75
[Pharmacologic bases of antiangina properties of amiodarone]. Brux Med (1970) 0.75
[A new therapeutic approach to menopausal sudden flushes and psychofunctional disorders (author's transl)]. Sem Hop (1980) 0.75
A potentially antianginal benzo [b]thiophene with an amiodarone-like haemodynamic profile. Arzneimittelforschung (1975) 0.75
[Subacute non suppurative thyroiditis. 20 cases]. Ann Endocrinol (Paris) (1975) 0.75
Some physiological responses to the stress of aqualung diving. Aerosp Med (1972) 0.75
[Low insertions of the ovum. Early detection by isotope scanning]. J Gynecol Obstet Biol Reprod (Paris) (1973) 0.75
A new potentially antianginal benzofuran with an amiodarone-like pharmacological profile. Arzneimittelforschung (1973) 0.75
[Blood levels of CA-50, CA-19.9, CA-125, enolase, CA-15.3 and carcinoembryonic antigen in non-cancerous bronchopulmonary pathology]. Rev Mal Respir (1988) 0.75
[Not Available]. Arch Int Pharmacodyn Ther (1955) 0.75
[Research on the benzofuran series. XXI. Inhibitory effect of phenolic benzofuran derivatives and of some analogues on rat liver xanthine oxidase in vitro]. Arch Int Pharmacodyn Ther (1967) 0.75
[Value of myoglobin radio-immuno-assay in myocardial infarction (author's transl)]. Sem Hop (1982) 0.75
[Is there a radiobiologic danger from supersonic transports?]. Presse Therm Clim (1970) 0.75
[Hydroxybenzylbenzofuran derivatives of pharmacological and therapeutic interest]. Actual Pharmacol (Paris) (1968) 0.75
Analysis of CA-125 levels in the sera of patients with non-ovarian carcinomas and non-malignant diseases. Anticancer Res (1989) 0.75
CA-50 and CA-19.9 as tumour markers: which is preferable? Anticancer Res (1990) 0.75
[Radioimmunoassay of plasma myoglobin in 102 cases of myocardial infarction]. Arch Mal Coeur Vaiss (1979) 0.75
[Gas-liquid chromatographic assay of a new antineoplastic agent, 1,3,3,5,5-pentakis-(azaridino)lambda 6-2,4,6,3 lambda 5, 5 lambda 5-thiatriazadiphosphorine-1-oxide. Application to pharmacokinetic studies]. J Chromatogr (1984) 0.75
[Propargylic derivatives. IX. Propargyl-pyrrolidinols and propargyl-perhydro-azepinols and their esters]. Helv Chim Acta (1969) 0.75
[Radioautographic procedures and their value in research (3d part)]. Rev Corps Sante Armees Terre Mer Air (1968) 0.75
[Research on a series of benzofurans. XXX. Action of amiodarone on phosphorylating oxidations of rat liver mitochondria]. Biochem Pharmacol (1968) 0.75
[Determination of carcinoembryonic antigen in effusion fluids]. Nouv Presse Med (1979) 0.75
[Hemodynamic effects of amiodarone in the thyroidectomized animal]. Arch Int Pharmacodyn Ther (1970) 0.75
[Lethal effect of ozone on certain aerobic bacteria strains in a model of the dental pulp chamber]. Rev Odontostomatol Midi Fr (1970) 0.75
Latex allergy in patient with allergy to fruit. Lancet (1992) 0.75
[Assay of the laminin P1 using a radioimmunologic technic: applications in oncology]. Bull Cancer (1989) 0.75
Current status of French research on the biological effects of heavy ions in cosmic radiation as observed in high-altitude balloons. Life Sci Space Res (1970) 0.75
[Oligospermias and the test for LH-RH]. Gynecologie (1977) 0.75
[CA-125 in non-ovarian benign and malignant pathology: study on 380 patients]. Bull Cancer (1989) 0.75
[Interpretation of the results of determination of placental lactogen hormone during normal pregnancy]. J Gynecol Obstet Biol Reprod (Paris) (1972) 0.75
[Studies on substances in the benzofuran group. 43. Angiotrophic, anti-inflammatory and fibrinolytic properties of benzarone]. Arzneimittelforschung (1970) 0.75
[Study of pancreatic excretion by use of methionine-S35]. J Physiol (Paris) (1966) 0.75
[Studies on the benzofuran series. XXVII. Antagonism of amiodarone with respect to certain cardiovascular and metabolic effects of catecholamines in dogs]. Arch Int Physiol Biochim (1967) 0.75
[Contributions of the measurement of TSH, T4 and thyroglobulin, of 99m Tc scintigraphy and of cervical ultrasonography to the early diagnosis of congenital hypothyroidism]. Pediatrie (1988) 0.75
[Assay of total blood estriol from capillary blood and by a micromethod]. Nouv Presse Med (1978) 0.75
[Development of pharmacologic criteria for development of antianginal medications]. Brux Med (1969) 0.75
[Pharmacology of the coronary circulation]. Rev Med Liege (1968) 0.75
[Research on the indole series. II. Anti-inflamatory and anti-arthritic properties of (isopropyl-2 indolyl)-3 pyridil-3 ketone]. Therapie (1974) 0.75
Multi-center study of a new technique for measuring free thyroxin in serum. Clin Chem (1989) 0.75
[Regulation of animal experimentation]. Therapie (1990) 0.75
[Anti-inflammatory and anti-arthritic properties of (5-chloro-3-methylbenzo (b) thien-2-yl)acetic acid]. Arch Int Pharmacodyn Ther (1974) 0.75
[Autoradiographic procedures and their interest in research. I]. Rev Corps Sante Armees Terre Mer Air (1967) 0.75
[Pharmacologic profile of a new non-competitive antiadrenergic agent with an anti-angina potential--a derivative of amiodarone]. Arch Int Pharmacodyn Ther (1973) 0.75
[Metabolic effects of various palliative drugs for coronary insufficiency]. Therapie (1972) 0.75
[Ultrasensitive TSH : a new diagnostic approach to hyperthyroidism]. Ann Endocrinol (Paris) (1986) 0.75
[Effects of certain hydroxy-benzoyl-benzofurans on the urinary tract]. Acta Urol Belg (1967) 0.75
[Comparative analysis of serum levels of CA-50, CA-125, CA-19.9, enolase and CEA in bronchopulmonary cancer]. Rev Pneumol Clin (1987) 0.75
Nature of the antiadrenergic properties of an indolizine. Arzneimittelforschung (1978) 0.75
[Studies in the benzofuran series. LV. Fibrinolytic properties of inicarone]. Therapie (1974) 0.75